ArticleNoro psikiyatri arsivi2026
The Prognostic Value of the CHA2DS2-VASc Score for Predicting In-Hospital Mortality and Short-Term Outcomes in Patients with Acute Ischemic Stroke.
Article in Noro psikiyatri arsivi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute ischemic stroke (AIS) is a common fatal neurological disease worldwide. This study aimed to investigate the prognostic value of the CHA2DS2-VASc score in patients with AIS. Methods: Two hundred and fifty patients admitted to the emergency department with a diagnosis of AIS without AF were prospectively enrolled in the study. Results: The CHA2DS2-VASc score, NIHSS score, initial stroke severity (ISS), cerebral infarct volume (CIV), and modified Rankin Scale (mRS) were significantly higher, whereas left ventricular ejection fraction (LVEF) and Barthell index (BI) were significantly lower in the in-hospital mortality (+) group. There was a statistically significant positive correlation of the CHA2DS2-VASc score with NIHSS score (r=0.389; p<0.001), ISS (r=0.417; p<0.001), mRS (r=0.362; p<0.001) and SIV (r=0.214; p<0.001) whereas a significant negative correlation of the CHA2DS2-VASc score with BI (r= -0.371; p<0.001). In multivariable Cox-regression analysis, we found that the CHA2DS2-VASc score (HR: 1.816; 95% CI: 1.209-2.726; p<0.001), congestive heart failure, NIHSS score, and BI were independent predictors of in-hospital mortality. Finally, in the Kaplan-Meier survival analysis, in-hospital mortality was significantly higher in patients with the CHA2DS2-VASc score ≥6 (log-rank p<0.001). Conclusion: The CHA2DS2-VASc score was established to be an independent predictor of in-hospital mortality and short-term outcomes in AIS patients without AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.